Bloom Energy Surges 12 on 26 Billion AI Data Center Deal with Nebius Indonesian Commodity Exporters Cite Multiple Obstacles in State Monopoly Proposal Pentagon Releases Decades of UFO Sightings Potential Implications for Defense and Technology Sectors Tree Dispute After Storm Damage Sparks 6000 Property Claim SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags Global Leaders Watch TrumpXi Summit for Trade and Economic Signals Farmland Partners Inc FPI Q1 2026 Earnings EPS Falls Short of Estimates Amid Lower Farm Income Zillow Group Q1 2026 Earnings EPS Surge Misses Wall Street Hope as Housing Headwinds Weigh STC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Title Volume Miller Industries MLR Q1 2026 Earnings EPS Misses by a Wide Margin as Profitability Pressures Mount VLYPO Q1 2026 Earnings Slight EPS Beat Amid Stable Operations SYRE Q1 2026 Earnings WiderthanExpected Loss Highlights Development Stage Challenges RingCentral RNG Surges 313 as Shares Approach Key Resistance MEDIROM Healthcare Technologies MRM Drops 1575 Key Support Levels in Focus Highland Global Allocation Fund HGLB Faces Pressure as Price Dips Below 810 Gyrodyne LLC GYRO Holds Steady at 711 as Support and Resistance Levels Define Trading Range Par Pacific Holdings PARR Holds Steady Near Midpoint as Energy Sector Consolidates Jim Cramer Analyzes NVIDIAs Latest Quarterly Performance Amid AI Momentum Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones Crescent Capital BDC CCAP Shows Modest Uptick Amid Steady Support Arqit Quantum Warrants ARQQW Surge 10 as Price Hovers at Key 008 Level XBiotech XBIT Edges Lower as Stock Tests Key Support Level Ironwood Pharmaceuticals IRWD Slides 49 as Support Levels Tested Near 352 Valneva VALN Holds Steady Near Support as Traders Weigh NearTerm Catalysts IVDAW Warrants Remain Static at 003 as Trading Activity Remains Subdued BayCom Corp BCML Edges Higher Analyzing Recent Momentum and Key Levels Apogee Therapeutics APGE Faces Steep Decline Testing Key Support Levels